BioWorld. Link to homepage.

Clarivate
  • BioWorld
  • BioWorld MedTech
  • BioWorld Asia
  • BioWorld Science
  • Data Snapshots
    • BioWorld
    • BioWorld MedTech
    • Infographics: Dynamic digital data analysis
    • Index insights
  • Special reports
    • Infographics: Dynamic digital data analysis
    • Trump administration impacts
    • Biopharma M&A scorecard
    • BioWorld 2024 review
    • BioWorld MedTech 2024 review
    • BioWorld Science 2024 review
    • Women's health
    • China's GLP-1 landscape
    • PFA re-energizes afib market
    • China CAR T
    • Alzheimer's disease
    • Coronavirus
    • More reports can be found here

BioWorld. Link to homepage.

  • Sign In
  • Sign Out
  • My Account
Subscribe
BioWorld - Thursday, July 3, 2025
Home » Topics » Briefs

Briefs
Briefs RSS Feed RSS

Appointments and advancements June 24, 2025

June 24, 2025
New hires and promotions in the med-tech industry, including: Medtronic, Moon Surgical, Neogenomics.
Read More

Financings for June 24, 2025

June 24, 2025
Med-tech firms raising money in public or private financings, including: Forsight, Jaan, Pavmed, Veris.
Read More

Other news to note for June 24, 2025

June 24, 2025
Med-tech happenings, including deals and partnerships, grants, preclinical data and other news in brief: Averra, Iridex, Mellingmedical, Nitinotes, Novogene, Photosound Technologies, Ratio Therapeutics, Siemens Medical Solutions, Terrapower, Trinity Biotech, Verasonics, Vivasure Medical, Zien Medical Technologies, Zynex.
Read More

Regulatory actions for June 24, 2025

June 24, 2025
Regulatory snapshots, including global submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Edwards, Tissium.
Read More

Regulatory actions for June 24, 2025

June 24, 2025
Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Alvotech, Advanz, Argenx, GSK, Idorsia, Incyte, Novadip, Partner, PTC, Revolution, Sanofi, Simcere.
Read More

Other news to note for June 24, 2025

June 24, 2025
Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Chuang, Carisma, Denovo, Enzon, Formation Bio, Hyloris, Idorsia, Kuvatris, Leap, Ono, Orthocellix, Purdue, Sanofi, Simcere, Viskase, Vertex.
Read More

In the clinic for June 24, 2025

June 24, 2025
Clinical updates, including trial initiations, enrollment status and data readouts and publications: AB Science, Cidara, Compass, Eli Lilly, Exelixis, Forte, H. Lundbeck, Immutep, J&J, Leap, Merck, Novo Nordisk, Pleopharma, Roche, Vertex.
Read More

Financings for June 24, 2025

June 24, 2025
Biopharmas raising money in public or private financings, including: Aptevo, Cyclacel, Eyenovia, Shuttle.
Read More

Appointments and advancements for June 24, 2025

June 24, 2025
New hires and promotions in the biopharma industry, including: Candel, Galapagos, Galaxy, MBX, Medicus, Oncusp, Rapt.
Read More

In the clinic for June 24, 2025

June 24, 2025
Clinical updates from Asia, including trial initiations, enrollment status and data readouts and publications: Akeso, Amplia, Ascentage, D&D Pharmatech, F2G.
Read More
Previous 1 2 3 4 5 6 7 8 9 10 11 12 … 1588 1589 Next

Popular Stories

  • Today's news in brief

    BioWorld
    BioWorld briefs for July 2, 2025.
  • Today's news in brief

    BioWorld MedTech
    BioWorld MedTech briefs for July 2, 2025.
  • Medtronic Vitalflow ECMO

    Medtronic receives CE mark for its Vitalflow ECMO system

    BioWorld MedTech
    Medtronic plc received a CE mark for its Vitalflow extracorporeal membrane oxygenation (ECMO) system, which provides temporary support for the heart and lungs in...
  • Drug vials

    Industry could feel fallout of Pfizer vaccine scrutiny

    BioWorld
    In subpoenaing a former Pfizer Inc. official to appear before the U.S. House Judiciary Committee July 22, Judiciary Chair Jim Jordan, R-Ohio, signaled legislative...
  • Illustration of the β2-adrenergic receptor

    Exercise-mimicking compound offers alternative to GLP-1 therapies

    BioWorld
    An experimental drug for treating diabetes and obesity has been shown to lower blood sugar levels and increase fat burning. It is a β2-adrenergic receptor (β2AR)...
  • BioWorld
    • Today's news
    • Analysis and data insight
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld MedTech
    • Today's news
    • Clinical
    • Data Snapshots
    • Deals and M&A
    • Financings
    • Newco news
    • Opinion
    • Regulatory
    • Science
  • BioWorld Asia
    • Today's news
    • Analysis and data insight
    • Australia
    • China
    • Clinical
    • Deals and M&A
    • Financings
    • Newco news
    • Regulatory
    • Science
  • BioWorld Science
    • Today's news
    • Biomarkers
    • Cancer
    • Conferences
    • Endocrine/Metabolic
    • Immune
    • Infection
    • Neurology/Psychiatric
    • Patents
  • More
    • About
    • Advertise with BioWorld
    • Archives
    • Article reprints and permissions
    • Contact us
    • Cookie policy
    • Copyright notice
    • Data methodology
    • Infographics: Dynamic digital data analysis
    • Index insights
    • Podcasts
    • Privacy policy
    • Share your news with BioWorld
    • Staff
    • Terms of use
    • Topic alerts
Follow Us

Copyright ©2025. All Rights Reserved. Design, CMS, Hosting & Web Development :: ePublishing